What does it take to stay prepared for a rare but potentially life-threatening anesthesia complication like malignant hyperthermia (MH)? Join us as Dr. Henry Rosenberg, a trailblazer in the field and founder of the Malignant Hyperthermia Association of the United States, shares his insights on the evolution of MH diagnosis and management. We promise you'll gain a deeper understanding of the transition from traditional muscle biopsy contracture tests to cutting-edge DNA diagnostic methods. Preparedness and vigilance are key themes as we explore the responsibilities of anesthesia professionals in ensuring patient safety for those susceptible to MH. We delve into the necessity of genetic counseling and multidisciplinary follow-up care, including consultations with geneticists and neurologists, to identify potential underlying conditions. Even if you never encounter a case of malignant hyperthermia in your career, understanding these strategies equips you to handle the unexpected. As we wrap up our discussions for 2024, we invite you to continue supporting our mission by sharing this knowledge-rich episode and leaving a five-star review. Your feedback drives our commitment to delivering valuable content on anesthesia patient safety.For show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/234-malignant-hyperthermia-preparedness-insights-and-updates/© 2024, The Anesthesia Patient Safety Foundation

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related